Contact Information
Company Information
Company
Autobahn Therapeutics, Inc.
Total Funding
208700000.0
Technologies
Outlook
Google Cloud Hosting
WordPress.org
Mobile Friendly
Nginx
Remote
AI
Keywords
biotechnology research
cns disorders
regenerative medicine
small molecule therapies
brain-targeting chemistry
thyroid hormone receptor
abx-002
bipolar disorder
major depressive disorder
clinical development
biomarker-driven development
neuropsychiatry
neuroimmunology
clinical trials
drug discovery
clinical data
therapeutic pipelines
human genetics
mental health treatments
precision medicine
pharmacology
sphingosine-1-phosphate
neuroinflammatory disorders
novel therapeutics
therapeutic candidates
proof-of-concept
oral administration
pharmacokinetics
clinical efficacy
patient-centered care
biologics
neuroprotective agents
drug formulation
therapeutic innovation
clinical research
treatment-resistant depression
safety profile
pharmacogenomics
therapeutic mechanisms
neurochemistry
cns pharmacology
investigator-initiated trials
patient engagement
cross-functional collaboration
healthcare partnerships
clinical insights
scientific communication
research partnerships
therapeutic exploration
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans